These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10701683)

  • 1. FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts.
    Migita K; Tanaka H; Okamoto K; Yoshikawa N; Ichinose Y; Urayama S; Yamasaki S; Ida H; Kawabe Y; Kawakami A; Eguchi K
    Lab Invest; 2000 Feb; 80(2):135-41. PubMed ID: 10701683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
    Yao HP; Shao XT; Sun WJ; Shao CS; Zhang LH
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):277-82. PubMed ID: 12621554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients.
    Yao H; Zhou J; Li D; Wu N; Bader A; Höxtermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2005 Mar; 10(3):110-6. PubMed ID: 15851377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.
    Inoue H; Umesono K; Nishimori T; Hirata Y; Tanabe T
    Biochem Biophys Res Commun; 1999 Jan; 254(2):292-8. PubMed ID: 9918831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes.
    Min SY; Hwang SY; Jung YO; Jeong J; Park SH; Cho CS; Kim HY; Kim WU
    J Rheumatol; 2004 May; 31(5):875-83. PubMed ID: 15124245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of glucocorticoid receptor (GR)-mediated signaling by the immunosuppressant tacrolimus in rheumatoid synoviocytes.
    Torigoshi T; Motokawa S; Miyashita T; Maeda Y; Koga T; Nakamura M; Komori A; Aiba Y; Uemura T; Yatsuhashi H; Ishibashi H; Eguchi K; Shindo H; Migita K
    Clin Exp Rheumatol; 2009; 27(2):246-52. PubMed ID: 19473564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mechanism of NF-kappaB inhibition by two glucocorticoid receptor modulators in rheumatoid arthritis synovial fibroblasts.
    Gossye V; Elewaut D; Bougarne N; Bracke D; Van Calenbergh S; Haegeman G; De Bosscher K
    Arthritis Rheum; 2009 Nov; 60(11):3241-50. PubMed ID: 19877072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.
    Faour WH; He Y; He QW; de Ladurantaye M; Quintero M; Mancini A; Di Battista JA
    J Biol Chem; 2001 Aug; 276(34):31720-31. PubMed ID: 11423555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells.
    Honda S; Migita K; Hirai Y; Ueki Y; Yamasaki S; Urayama S; Kawabe Y; Fukuda T; Kawakami A; Kamachi M; Kita M; Ida H; Aoyagi T; Eguchi K
    Biochem Biophys Res Commun; 2000 Feb; 268(3):928-31. PubMed ID: 10679307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor.
    Sampey AV; Hall PH; Mitchell RA; Metz CN; Morand EF
    Arthritis Rheum; 2001 Jun; 44(6):1273-80. PubMed ID: 11407686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
    Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
    Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of interleukin-1 beta-induced cyclooxygenase-2 gene expression by nimesulide in human synovial fibroblasts.
    Di Battista JA; Fahmi H; He Y; Zhang M; Martel-Pelletier J; Pelletier JP
    Clin Exp Rheumatol; 2001; 19(1 Suppl 22):S3-5. PubMed ID: 11296546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha.
    Han CW; Choi JH; Kim JM; Kim WY; Lee KY; Oh GT
    Rheumatology (Oxford); 2001 Mar; 40(3):267-73. PubMed ID: 11285373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
    Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
    J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Triptolide on TNFalpha-induced activation of NF-kappaB and expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts].
    Shao XT; Feng L; Yao HP; Sun WJ; Zhang LH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 33(2):160-5. PubMed ID: 15067740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.
    Sugiyama E; Taki H; Kuroda A; Mino T; Yamashita N; Kobayashi M
    Ann Rheum Dis; 1996 Jun; 55(6):375-82. PubMed ID: 8694577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts.
    Migita K; Miyashita T; Maeda Y; Aoyagi T; Kawabe Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
    Immunol Lett; 2005 May; 98(2):194-9. PubMed ID: 15860218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.